Psoriatic Arthritis Clinical Trials

Emeritus Research is proud to be running clinical trials to investigate whether new medicines can improve Psoriatic Arthritis for patients.

Emeritus’ leading Rheumatologists have been working with global pharmaceutical companies for over 20 years, and have been part of research that developed many of today’s leading medicines.

Psoriatic arthritis is a chronic disease characterized by pain, inflammation and swelling in joints and regions where ligaments and tendons connect with bone. While predominantly observed in the joints of the hands, feet and limbs, psoriatic arthritis can cause severe discomfort in many other parts of the body as well. Those diagnosed with psoriatic arthritis may also experience limited movement in their joints, changes to their nails, along with the skin inflammation, flakiness, and other psoriasis like rash symptoms.

Without effective treatment, psoriatic arthritis symptoms may increase in severity over time due to the progressive nature of the disease. However, various medications which are already approved have been shown to reduce these symptoms for some people.

Emeritus Research is proud to be running multiple trials investigating potentially new medications for people suffering from psoriatic arthritis.

If you’re interested in learning more about our psoriatic arthritis trials please express your interest by filling out the below interactive video OR google form

Interactive Video
Google Form

Google Form

Interactive Video

Benefits of being involved in our clinical research include:

  • No costs for the visits or medications
  • Payment for your time and travel
  • Dedicated healthcare professionals who will work with you throughout the study
  • Contributing to research that seeks to help other people living with chronic disease

Our past research was recently recognised by Channel 9 News.

Coronavirus
Safety

Emeritus Research is a dedicated clinical trials site that will not be seeing any patients with coronavirus symptoms. All patients will receive hospital-grade sanitiser upon arrival, and are escorted to a private consulting room for their visits – no waiting rooms. We want to ensure our patients can feel confident that they will receive treatment for their chronic disease during this challenging time.